METAL COMPLEX AND USE THEREOF
20230295204 · 2023-09-21
Assignee
Inventors
Cpc classification
H10K59/70
ELECTRICITY
Y02E10/549
GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
C07F15/00
CHEMISTRY; METALLURGY
International classification
C07F15/00
CHEMISTRY; METALLURGY
Abstract
The present invention relates to a metal complex and application thereof. The metal complex has a general formula of Ir(La)(Lb)(Lc), and includes a structure as shown in the following formula (1) as a ligand La. The metal complex provided in the present invention has the advantages of high optical and electrical stability, high luminescence efficiency, long service life, and high color saturation, and can be used in organic light-emitting devices. In particular, the metal complex has the potential for application in the AMOLED industry as a red light-emitting phosphorescent material.
##STR00001##
Claims
1. A metal complex, having a general formula of Ir(La)(Lb)(Lc), and comprising a ligand La as shown in the following formula (1), ##STR00419## wherein among A.sub.1-A.sub.4, one group is a C—C bond connected to an E ring, one group is a C-metal bond connected to a metal, one group is CR.sub.4, and the other group is CR.sub.0 or N; among A.sub.5-A.sub.8, one group is CR.sub.3, and the other three groups independently refer to CR.sub.0 or N; the number of R.sub.1-R.sub.2 is a maximum substitution number; R.sub.0-R.sub.4 are independently selected from hydrogen, deuterium, halogen, substituted or unsubstituted C.sub.1-C.sub.10 alkyl, substituted or unsubstituted C.sub.3-C.sub.20 cycloalkyl, substituted or unsubstituted C.sub.1-C.sub.10 heteroalkyl, substituted or unsubstituted C.sub.7-C.sub.30 aralkyl, substituted or unsubstituted C.sub.1-C.sub.10 alkoxy, substituted or unsubstituted C.sub.6-C.sub.30 aryloxy, substituted or unsubstituted C.sub.2-C.sub.20 alkenyl, substituted or unsubstituted C.sub.3-C.sub.30 silyl, substituted or unsubstituted C.sub.6-C.sub.30 aryl, substituted or unsubstituted C.sub.3-C.sub.30 heteroaryl, substituted or unsubstituted C.sub.3-C.sub.30 arylsilyl, substituted or unsubstituted C.sub.0-C.sub.20 amino, cyano, nitrile, isonitrile, and phosphino; at least one of R.sub.3 and R.sub.4 is not hydrogen; when A.sub.7 is CR.sub.0, R.sub.0 is not F; X is independently selected from O, S, Se, C(R).sub.2, Si(R).sub.2, NR, BR, and POR; the R is independently selected from substituted or unsubstituted C.sub.1-C.sub.10 alkyl or alkoxy, substituted or unsubstituted C.sub.2-C.sub.30 cycloalkyl, substituted or unsubstituted C.sub.6-C.sub.30 aryl, and substituted or unsubstituted C.sub.1-C.sub.18 heteroaryl; the “substituted” refers to substitution with deuterium, F, Cl, Br, C.sub.1-C.sub.4 alkyl, C.sub.1-C.sub.4 alkoxy, C.sub.3-C.sub.6 cycloalkyl, amino substituted with C.sub.1-C.sub.4 alkyl, cyano, nitrile, isonitrile, and phosphino; a heteroatom in the heteroalkyl or heteroaryl is at least one of S, O, and N; a dotted line refers to a bond connected to metal iridium; La, Lb, and Lc are different from each other, and any two of the three groups are connected to form a multidentate ligand, or the three groups are connected by a group; both the Lb and the Lc are a monoanionic bidentate ligand; and the “different from each other” refers to having different parent nucleus structures, having a same parent nucleus structure with different substituents, or having a same parent nucleus structure with a same substituent at different positions.
2. The metal complex according to claim 1, having a structure as shown in the following formula (2): ##STR00420## wherein the A is CR.sub.0 or N; the R.sub.0-R.sub.4 are independently selected from hydrogen, deuterium, halogen, substituted or unsubstituted C.sub.1-C.sub.10 alkyl, substituted or unsubstituted C.sub.3-C.sub.20 cycloalkyl, substituted or unsubstituted C.sub.1-C.sub.10 heteroalkyl, substituted or unsubstituted C.sub.7-C.sub.30 aralkyl, substituted or unsubstituted C.sub.1-C.sub.10 alkoxy, substituted or unsubstituted C.sub.6-C.sub.30 aryloxy, substituted or unsubstituted C.sub.2-C.sub.20 alkenyl, substituted or unsubstituted C.sub.3-C.sub.30 silyl, substituted or unsubstituted C.sub.6-C.sub.30 aryl, substituted or unsubstituted C.sub.3-C.sub.30 heteroaryl, substituted or unsubstituted C.sub.3-C.sub.30 arylsilyl, substituted or unsubstituted C.sub.0-C.sub.20 amino, cyano, nitrile, isonitrile, and phosphino; at least one of the R.sub.3 and the R.sub.4 is not hydrogen; and the X, the Lb, and the Lc are defined the same as above.
3. The metal complex according to claim 2, wherein the A is CH or N.
4. The metal complex according to claim 3, wherein the A is N, and the R.sub.3 substituent is located adjacent to the N.
5. The metal complex according to claim 4, wherein the R.sub.3 is D, C.sub.1-C.sub.4 alkyl, or C.sub.1-C.sub.4 alkyl including at least one D.
6. The metal complex according to claim 5, wherein the R.sub.3 is CD.sub.3.
7. The metal complex according to claim 2, wherein the R.sub.4 substituent is located adjacent or opposite to a metal Ir-carbon bond.
8. The metal complex according to claim 2, having one of the following structures: ##STR00421## wherein the R.sub.1 and the R.sub.2 have a maximum substitution number; the R.sub.1-R.sub.2 are independently selected from hydrogen, substituted or unsubstituted C.sub.1-C.sub.6 alkyl, substituted or unsubstituted C.sub.3-C.sub.6 cycloalkyl, substituted or unsubstituted C.sub.7-C.sub.20 aralkyl, substituted or unsubstituted C.sub.3-C.sub.30 heteroaryl, or substituted or unsubstituted C.sub.6-C.sub.30 aryl; at least one of the R.sub.1 and the R.sub.2 is not hydrogen; the R.sub.3 and the R.sub.4 are independently selected from hydrogen, substituted or unsubstituted C.sub.1-C.sub.6 alkyl, and substituted or unsubstituted C.sub.3-C.sub.10 cycloalkyl; at least one of the R.sub.3 and the R.sub.4 is not hydrogen; the X is independently selected from O, S, Se, C(R).sub.2, Si(R).sub.2, and NR; the R is independently selected from substituted or unsubstituted C.sub.1-C.sub.10 alkyl or alkoxy, substituted or unsubstituted C.sub.3-C.sub.30 cycloalkyl, and substituted or unsubstituted C.sub.6-C.sub.30 aryl; and the “substituted” refers to substitution with deuterium, F, Cl, Br, or C.sub.1-C.sub.4 alkyl.
9. The metal complex according to claims 1 to 8, wherein the X is O, S, Se, NR, or C(R).sub.2; and the R is independently selected from substituted or unsubstituted C.sub.1-C.sub.8 alkyl.
10. The metal complex according to claim 1, wherein the La is independently selected from one of the following structural formulas, corresponding parts or complete deuterides thereof, or corresponding parts or complete fluorides thereof; TABLE-US-00003
11. The metal complex according to claim 1, wherein the Lb and the Lc are independently selected from any one of La1 to La1307 according to claim 10, corresponding parts or complete deuterides thereof, or corresponding parts or complete fluorides thereof; and the La, the Lb, and the Lc do not have a structure of the same number.
12. The metal complex according to any one of claims 1 to 10, wherein the Lb and the Lc are independently selected from one of the following structural formulas (a) to (k): ##STR00729## a dotted line refers to a bond connected to metal iridium; the number of Ra, Rb, and Rc is a maximum substitution number; the Ra, the Rb, and the Rc are independently selected from hydrogen, deuterium, halogen, substituted or unsubstituted C.sub.1-C.sub.20 alkyl, substituted or unsubstituted C.sub.3-C.sub.30 cycloalkyl, substituted or unsubstituted C.sub.1-C.sub.30 heteroalkyl, substituted or unsubstituted C.sub.7-C.sub.30 aralkyl, substituted or unsubstituted C.sub.1-C.sub.20 alkoxy, substituted or unsubstituted C.sub.6-C.sub.30 aryloxy, substituted or unsubstituted C.sub.2-C.sub.20 alkenyl, substituted or unsubstituted C.sub.3-C.sub.30 silyl, substituted or unsubstituted C.sub.6-C.sub.30 aryl, substituted or unsubstituted C.sub.3-C.sub.30 heteroaryl, substituted or unsubstituted C.sub.3-C.sub.30 arylsilyl, substituted or unsubstituted C.sub.0-C.sub.20 amino, cyano, nitrile, isonitrile, and phosphino; or two adjacent substituents are optionally connected into a ring or fused structure; the “substituted” refers to substitution with deuterium, F, Cl, Br, C.sub.1-C.sub.10 alkyl, C.sub.1-C.sub.10 alkoxy, C.sub.3-C.sub.10 cycloalkyl, amino substituted with C.sub.1-C.sub.10 alkyl, C.sub.6-C.sub.30 aryl, C.sub.7-C.sub.30 aralkyl, cyano, nitrile, isonitrile, and phosphino; and a heteroatom in the heteroalkyl or heteroaryl is at least one of S, O, and N.
13. The metal complex according to claim 12, wherein the Lb and the Lc are independently selected from the following structural formulas, corresponding parts or complete deuterides thereof, or corresponding parts or complete fluorides thereof; and the Lb and the Lc are not a ligand of the same number. ##STR00730## ##STR00731## ##STR00732## ##STR00733## ##STR00734## ##STR00735## ##STR00736## ##STR00737## ##STR00738## ##STR00739## ##STR00740## ##STR00741## ##STR00742## ##STR00743## ##STR00744## ##STR00745## ##STR00746## ##STR00747## ##STR00748## ##STR00749## ##STR00750## ##STR00751## ##STR00752## ##STR00753## ##STR00754## ##STR00755## ##STR00756## ##STR00757## ##STR00758## ##STR00759## ##STR00760## ##STR00761## ##STR00762## ##STR00763## ##STR00764## ##STR00765## ##STR00766## ##STR00767## ##STR00768## ##STR00769## ##STR00770## ##STR00771## ##STR00772## ##STR00773## ##STR00774## ##STR00775## ##STR00776## ##STR00777## ##STR00778## ##STR00779## ##STR00780## ##STR00781## ##STR00782##
14. An electroluminescent device, comprising a cathode, an anode, and organic layers arranged between the cathode and the anode, wherein at least one of the organic layers comprises the metal complex according to any one of claims 1 to 13.
15. The electroluminescent device according to claim 14, wherein the organic layers comprise a light-emitting layer, and the metal complex according to any one of claims 1 to 13 is used a red light-emitting doping material for the light-emitting layer; or the organic layers comprise a hole injection layer, and the metal complex according to any one of claims 1 to 13 is used as a hole injection material for the hole injection layer.
Description
DETAILED DESCRIPTION OF EMBODIMENTS
[0046] The following embodiments are merely described to facilitate the understanding of the technical invention, and should not be considered as specific limitations of the present invention.
[0047] All raw materials, solvents and the like involved in the synthesis of compounds in the present invention were purchased from Alfa, Acros, and other suppliers known to persons skilled in the art.
Example 1 Synthesis of a Compound A1
Synthesis of Ligands L50 and La385
[0048] ##STR00367##
Synthesis of a Compound L50
[0049] A compound L1-1 (36.0 g, 155.3 mmol, 1.0 eq), a compound L1-2 (23.3 g, 155.3 mmol, 1.0 eq), potassium carbonate (42.9 g, 310.7 mmol, 2.0 eq), and bis(di-tert-butyl(4-dimethylaminophenyl)phosphine)dichloropalladium (II) (1.02 g, 1.5 mmol, 0.01 eq) were put into a 1 L three-mouth flask, and toluene (360 ml), ethanol (96 ml), and deionized water (96 ml) were added under the replacement of vacuum and nitrogen for 3 times. A mixture obtained was heated to 80° C., and stirred for a reaction for 6 hours under the protection of nitrogen. According to monitoring by TLC (with a mixture of ethyl acetate and n-hexane at a ratio of 1:10 as a developing agent), the raw material L1-1 was almost consumed completely. Cooling was conducted to room temperature, and liquid separation was conducted. An organic phase was washed with water (3*180 ml). An aqueous phase was extracted with ethyl acetate (150 ml) for 1 time. Suction filtration was conducted with silica gel. Washing was conducted with ethyl acetate until no obvious product residue existed. Concentration was conducted to obtain a yellow viscous liquid. The liquid was separated by column chromatography (with a mixture of ethyl acetate and n-hexane at a ratio of 1:20 as an eluent), and then concentration and drying were conducted to obtain 41.2 g of a white sugar-like solid compound L50 with a yield of 87.8%. Mass spectrometry was as follows: 302.4 (M+H)
Synthesis of a Compound La385
[0050] A compound L1-1 (28.7 g, 123.8 mmol, 1.0 eq), a compound L1-3 (28.5 g, 126.3 mmol, 1.02 eq), K.sub.2CO.sub.3 (34.2 g, 247.7 mmol, 2.0 eq), and bis(di-tert-butyl(4-dimethylaminophenyl)phosphine)dichloropalladium (II) (0.81 g, 1.24 mmol, 0.01 eq) were put into a 1 L three-mouth flask, and toluene (290 ml), ethanol (90 ml), and H.sub.2O (90 ml) were added under the replacement of vacuum and nitrogen for 3 times. A mixture obtained was heated to 80° C., and stirred for a reaction for 3 hours under the protection of nitrogen. According to monitoring by TLC (with a mixture of ethyl acetate and n-hexane at a ratio of 1:8 as a developing agent), the raw material L1-1 was almost consumed completely. Cooling was conducted to room temperature, and liquid separation was conducted. An organic phase was washed with water (3*180 ml). An aqueous phase was extracted with ethyl acetate (150 ml) for 1 time. Suction filtration was conducted with silica gel. Washing was conducted with ethyl acetate until no obvious product residue existed. Concentration was conducted to obtain a yellow viscous liquid. The liquid was separated by column chromatography (with a mixture of ethyl acetate and n-hexane at a ratio of 1:20 as an eluent), and then concentration and drying were conducted to obtain 36.8 g of a white sugar-like solid compound La385 with a yield of 78.9%. Mass spectrometry was as follows: 378.4 (M+H)
Synthesis of a Compound A1
[0051] ##STR00368## ##STR00369##
Synthesis of a Compound A1-1
[0052] The compound L50 (6.7 g, 22.2 mmol, 2.0 eq) and silver oxide (2.58 g, 11.1 mmol, 1.0 eq) were added into a 250 ml three-mouth flask, and then a 4 A molecular sieve (2.5 g) and dichloromethane (130 ml) were added, and stirred at room temperature for 2 hours under the replacement of vacuum and nitrogen for 3 times until a solution became a brownish black suspension. According to monitoring by TLC (with a mixture of ethyl acetate and n-hexane at a ratio of 1:8 as a developing agent), the raw material L50 was almost consumed completely. Then, chloro(1,5-cyclooctadiene)iridium dimer (7.47 g, 11.1 mmol, 1.0 eq) was added into the reaction solution, and continuously stirred at room temperature for 8 hours until the solution became brownish red. According to monitoring by TLC (with a mixture of ethyl acetate and n-hexane at a ratio of 1:3 as a developing agent), a reaction was stopped until a product with high polarity was produced. After filtration was conducted, a filter cake was washed with a small amount of dichloromethane, and a filtrate was collected, and concentrated to about 60 ml. N-hexane (100 ml) was added, and stirred for 1 hour until a solid was precipitated out. The solid was rinsed with a small amount of n-hexane, filtered, and then dried to obtain 12.9 g of an orange red solid compound A1-1 with a yield of 91.8%. Mass spectrometry was as follows: 635.2 (M+H)
Synthesis of a Compound A1-2
[0053] The compound A1-1 (4.2 g, 6.61 mmol, 1.0 eq), the compound La385 (7.48 g, 19.8 mmol, 3.0 eq), and 2-ethoxyethanol (63 ml) were added into a 250 ml three-mouth flask, heated to 120° C., and stirred for 16 hours under the replacement of vacuum and nitrogen for 3 times. According to monitoring by TLC (with a mixture of ethyl acetate and n-hexane at a ratio of 1:3 as a developing agent), the raw material A-1 was almost consumed completely. A reaction solution was cooled to room temperature, and methanol (63 ml) was added into the reaction solution, and continuously stirred for 2 hours. After filtration was conducted, a filter cake was washed with a small amount of methanol, and then dried to obtain 3.8 g of an orange red solid compound A1-2 with a yield of 53.2%. The obtained compound was directly used in the next step without purification.
Synthesis of a Compound A1
[0054] The compound A1-2 (5.18 g), a compound L5 (4.91 g, 23.1 mmol, 3.5 eq), sodium carbonate (3.5 g, 33.0 mmol, 5.0 eq), and 2-ethoxyethanol (103 ml) were added into a 250 ml three-mouth flask, heated to 40° C., and stirred for 16 hours under the replacement of vacuum and nitrogen for 3 times. According to monitoring by TLC (with a mixture of ethyl acetate and n-hexane at a ratio of 1:5 as a developing agent), the raw material A1-2 was almost consumed completely. Then, methanol (103 ml) was added into a reaction solution, and continuously stirred at room temperature for 1 hour. After filtration was conducted, a filter cake was rinsed with a small amount of methanol. A solid obtained was stirred in dichloromethane (150 ml) for dissolved clarification. After filtration was conducted with silica gel, a filter cake was rinsed with a small amount of dichloromethane. Deionized water was added into a filtrate obtained for washing for 3 times (80 ml/time). Liquid separation was conducted, and an organic phase was collected, and spin-dried. A crude product was recrystallized with tetrahydrofuran/methanol (1 g/7 v/10 v) for 3 times, and then dried to obtain 3.8 g of a red solid compound A1 with a yield of 53.2%. 3.8 g of the crude product A1 was sublimated and purified to obtain 2.78 g of a sublimated pure product A1 with a yield of 73.1%. Mass spectrometry was as follows: 1081.4 (M+H). 1H NMR (400 MHz, CDCl.sub.3) δ 8.36 (d, J=15.0 Hz, 2H), 8.07 (d, J=2.9 Hz, 2H), 7.98 (dd, J=14.6, 3.4 Hz, 1H), 7.77 (d, J=15.0 Hz, 2H), 7.54 (dd, J=14.7, 3.4 Hz, 1H), 7.47 (dd, J=14.9, 3.0 Hz, 2H), 7.38 (tt, J=9.2, 4.5 Hz, 3H), 7.31 (td, J=14.8, 3.4 Hz, 2H), 6.92 (d, J=3.1 Hz, 2H), 2.32 (d, J=15.0 Hz, 9H), 2.02-1.82 (m, 4H), 1.81-1.55 (m, 12H), 1.42-1.15 (m, 8H), 1.11-0.97 (m, 5H), 0.94 (t, J=13.2 Hz, 12H).
Example 2 Synthesis of a Compound A2
Synthesis of ligands La193 and La769
[0055] ##STR00370##
Synthesis of a Compound La193
[0056] With reference to the synthesis process and post-treatment and purification methods of the compound La385, only the corresponding raw materials were required to be changed. Mass spectrometry was as follows: 366.2 (M+H).
Synthesis of a Compound La769
[0057] With reference to the synthesis process and post-treatment and purification methods of the compound La385, only the corresponding raw materials were required to be changed. Mass spectrometry was as follows: 414.5 (M+H).
Synthesis of a Compound A2
[0058] ##STR00371##
Synthesis of a Compound A2-1
[0059] With reference to the synthesis process and post-treatment and purification methods of the compound A1-1, only the corresponding raw materials were required to be changed. Mass spectrometry was as follows: 712.3 (M+H).
Synthesis of a Compound A2-2
[0060] With reference to the synthesis process and post-treatment and purification methods of the compound A1-2, only the corresponding raw materials were required to be changed. The obtained compound was directly used in the next step without purification.
Synthesis of a Compound A2
[0061] With reference to the synthesis process and post-treatment and purification methods of the compound A1, only the corresponding raw materials were required to be changed, and 2.95 g of a target compound A2 with a yield of 48.9% was obtained. 2.95 g of the crude product A2 was sublimated and purified to obtain 2.08 g of a sublimated pure product A2 with a yield of 70.5%. Mass spectrometry was as follows: 1181.4 (M+H). .sup.1H NMR (400 MHz, CDCl.sub.3) δ 8.38 (d, J=20.0 Hz, 2H), 7.98 (dd, 2H), 7.78 (m, J=5.0 Hz, 2H), 7.53 (d, J=15.0 Hz, 4H), 7.47 (m, 2H), 7.39 (m, 4H), 7.31 (m, 4H), 2.43 (d, 2H), 2.34 (s, 6H), 1.88 (m, 1H), 1.81 (m, J=7.2 Hz, 2H), 1.69 (m, J=37.5 Hz, 2H), 1.31 (m, 4H), 1.24 (m, 4H), 1.01 (m, J=5.7 Hz, 7H), 0.94 (m, 12H), 0.87 (d, 5H).
Example 3 Synthesis of a Compound A3
[0062] ##STR00372## ##STR00373##
Synthesis of a Compound A3
[0063] With reference to the synthesis process and post-treatment and purification methods of the compound A1, only the corresponding raw materials were required to be changed, and 3.11 g of a target compound A3 with a yield of 50.2% was obtained. 3.11 g of the crude product A3 was sublimated and purified to obtain 2.17 g of a sublimated pure product A3 with a yield of 69.7%. Mass spectrometry was as follows: 1193.5 (M+H). .sup.1H NMR (400 MHz, CDCl.sub.3) δ 8.38 (d, J=20.0 Hz, 2H), 7.94 (dd, 2H), 7.72 (m, J=5.0 Hz, 2H), 7.55 (d, J=15.0 Hz, 4H), 7.46 (m, 2H), 7.39 (m, 4H), 7.31 (m, 4H), 2.34 (s, 6H), 1.88 (m, 3H), 1.77 (t, J=18.8 Hz, 3H), 1.66 (m, J=2.2 Hz, 5H), 1.31 (m, 4H), 1.24 (m, 4H), 1.01 (m, J=5.7 Hz, 8H), 0.94 (m, 12H).
Example 4 Synthesis of a Compound A4
Synthesis of a Ligand La1306
[0064] ##STR00374##
Synthesis of a Compound La1306
[0065] With reference to the synthesis process and post-treatment and purification methods of the compound La385, only the corresponding raw materials were required to be changed. Mass spectrometry was as follows: 406.4 (M+H).
Synthesis of a Compound A4
[0066] ##STR00375##
Synthesis of a Compound A4-1
[0067] With reference to the synthesis process and post-treatment and purification methods of the compound A1-2, only the corresponding raw materials were required to be changed. The obtained compound was directly used in the next step without purification.
Synthesis of a Compound A4
[0068] With reference to the synthesis process and post-treatment and purification methods of the compound A1, only the corresponding raw materials were required to be changed, and 2.71 g of a target compound A4 with a yield of 47.7% was obtained. 2.71 g of the crude product A4 was sublimated and purified to obtain 1.95 g of a sublimated pure product A4 with a yield of 71.9%. Mass spectrometry was as follows: 1173.4 (M+H). .sup.1H NMR (400 MHz, CDCl.sub.3) δ 8.41 (d, J=20.0 Hz, 2H), 7.96 (dd, 2H), 7.75 (m, J=5.0 Hz, 2H), 7.56 (d, J=15.0 Hz, 4H), 7.47 (m, 2H), 7.40 (m, 4H), 7.33 (m, 4H), 2.63 (t, 2H), 2.43 (d, 1H), 2.34 (s, 6H), 1.85 (m, J=32.9 Hz, 2H), 1.31 (m, 4H), 1.24 (m, 4H), 1.01 (m, J=5.7 Hz, 5H), 0.94 (m, 12H), 0.87 (m, 6H).
Example 5 Synthesis of a Compound A5
Synthesis of a Ligand La1
[0069] ##STR00376##
Synthesis of a Compound La1
[0070] With reference to the synthesis process and post-treatment and purification methods of the compound La385, only the corresponding raw materials were required to be changed. Mass spectrometry was as follows: 352.4 (M+H).
Synthesis of a Compound A5
[0071] ##STR00377##
Synthesis of a Compound A5-1
[0072] With reference to the synthesis process and post-treatment and purification methods of the compound A1-2, only the corresponding raw materials were required to be changed. The obtained compound was directly used in the next step without purification.
Synthesis of a Compound A5
[0073] With reference to the synthesis process and post-treatment and purification methods of the compound A1, only the corresponding raw materials were required to be changed, and 2.88 g of a target compound A5 with a yield of 49.2% was obtained. 2.88 g of the crude product A5 was sublimated and purified to obtain 2.03 g of a sublimated pure product A5 with a yield of 70.4%. Mass spectrometry was as follows: 1135.5 (M+H). .sup.1H NMR (400 MHz, CDCl.sub.3) δ 8.36 (d, J=15.0 Hz, 2H), 8.07 (d, J=2.9 Hz, 2H), 7.98 (dd, J=14.6, 3.4 Hz, 1H), 7.77 (d, J=15.0 Hz, 2H), 7.54 (dd, J=14.7, 3.4 Hz, 1H), 7.47 (dd, J=14.9, 3.0 Hz, 2H), 7.38 (tt, J=9.2, 4.5 Hz, 3H), 7.31 (td, J=14.8, 3.4 Hz, 2H), 6.92 (d, J=3.1 Hz, 2H), 2.87 (m, J=6.5 Hz, 1H), 2.32 (d, J=15.0 Hz, 9H), 1.88 (m, 2H), 1.76 (m, 2H), 1.66 (m, J=2.2 Hz, 4H), 1.52 (m, J=30.0 Hz, 8H), 1.39 (m, 4H), 1.27 (d, J=30.0 Hz, 3H), 1.20 (m, 6H), 1.00 (m, 5H), 0.87 (s, 12H).
Example 6 Synthesis of a Compound A6
Synthesis of a Compound A6
[0074] ##STR00378##
[0075] With reference to the synthesis process and post-treatment and purification methods of the compound A1, only the corresponding raw materials were required to be changed, and 3.61 g of a target compound A6 with a yield of 54.2% was obtained. 3.61 g of the crude product A6 was sublimated and purified to obtain 2.61 g of a sublimated pure product A6 with a yield of 72.0%. Mass spectrometry was as follows: 1121.5 (M+H). .sup.1H NMR (400 MHz, CDCl.sub.3) δ 8.36 (d, J=15.0 Hz, 2H), 8.07 (d, J=2.9 Hz, 2H), 7.98 (dd, J=14.6, 3.4 Hz, 1H), 7.77 (d, J=15.0 Hz, 2H), 7.54 (dd, J=14.7, 3.4 Hz, 1H), 7.47 (dd, J=14.9, 3.0 Hz, 2H), 7.38 (tt, J=9.2, 4.5 Hz, 3H), 7.31 (td, J=14.8, 3.4 Hz, 2H), 6.92 (d, J=3.1 Hz, 2H), 2.87 (m, 1H), 2.54 (d, 2H), 2.32 (d, J=15.0 Hz, 9H), 1.88 (d, J=5.4 Hz, 4H), 1.83-1.73 (m, 8H), 1.67 (m, J=16.1, 6.1 Hz, 10H), 1.31 (m, 4H), 1.20 (m, J=2.6 Hz, 8H), 1.11 (m, 2H), 1.01 (m, J=15.0 Hz, 6H).
Example 7 Synthesis of a Compound A7
Synthesis of a Ligand L221
[0076] ##STR00379##
Synthesis of a Compound L112
[0077] A compound L10-1 (14.2 g, 82.5 mmol, 1.0 eq), a compound L10-2 (25.5 g, 82.5 mmol, 1.0 eq), tripotassium phosphate (35.0 g, 165.0 mmol, 2.0 eq), tris(dibenzylideneacetone)dipalladium (1.51 g, 1.65 mmol, 0.02 eq), and 2-dicyclohexylphosphino-2′,6′-dimethoxybiphenyl (1.36 g, 3.3 mmol, 0.04 eq) were put into a 500 ml three-mouth flask, and toluene (150 ml) and deionized water (30 ml) were added under the replacement of vacuum and nitrogen for 3 times. A mixture obtained was heated to reflux, and stirred for a reaction overnight under the protection of nitrogen. According to monitoring by TLC (with a mixture of ethyl acetate and n-hexane at a ratio of 1:5 as a developing agent), the raw material L10-2 was almost consumed completely. The mixture was cooled to room temperature. Liquid separation was conducted, and an organic phase was collected. An aqueous phase was extracted with ethyl acetate (60 ml) for 1 time. Organic phases were combined, and concentrated to obtain a yellow viscous liquid. The liquid was separated by column chromatography (with a mixture of ethyl acetate and n-hexane at a ratio of 1:15 as an eluent), and then concentration and drying were conducted to obtain 16.1 g of a white-like solid compound L112 with a yield of 71.5%. Mass spectrometry was as follows: 275.3 (M+H)
Synthesis of a Compound L221
[0078] The compound L112 (16.1 g, 58.6 mmol, 1.0 eq), sodium hydride (4.23 g, 176.0 mmol, 3.0 eq), and deuterated ethanol (160 ml) were added into a 500 ml three-mouth flask under the replacement of vacuum and nitrogen for 3 times. A mixture obtained was heated to reflux, and stirred for a reaction for 48 hours under the protection of nitrogen. Cooling was conducted to room temperature. Heavy water (100 ml) was added, and stirred for 0.5 hour. Dichloromethane (250 ml) was added for extraction twice. An organic phase in the lower layer was collected, and spin-dried. An aqueous phase was extracted with ethyl acetate (60 ml) for 1 time. Organic phases were combined, and concentrated to obtain a yellow viscous liquid. The liquid was separated by column chromatography (with a mixture of ethyl acetate and n-hexane at a ratio of 1:15 as an eluent), and then concentration and drying were conducted to obtain 10.1 g of a white-like solid compound L221 with a yield of 62.1%. Mass spectrometry was as follows: 278.3 (M+H)
Synthesis of a Compound A7
[0079] ##STR00380##
[0080] The compound A5-1 (8.2 g, 4.7 mmol, 1.0 eq) and dichloromethane (205 ml) were added into a 250 ml three-mouth flask for stirring and dissolution, and silver trifluoromethanesulfonate (2.66 g, 10.3 mmol, 2.2 eq) was dissolved in isopropanol (66.5 ml), and then dropped into the three-mouth flask under the atmosphere of nitrogen. A mixture obtained was stirred at room temperature for a reaction for 18 hours. A reaction suspension was filtered with diatomite to remove a silver salt. A filtrate was spin-dried to obtain an orange red solid, which was directly used in a reaction in the next step without purification. The solid obtained, the compound L221 (3.91 g, 14.1 mmol, 3.0 eq), and ethanol (117 ml) were added into a 250 ml clean three-mouth flask under the replacement of vacuum and nitrogen for 3 times. A mixture obtained was heated to reflux, and stirred overnight. According to monitoring by TLC (with a mixture of ethyl acetate and n-hexane at a ratio of 1:5 as a developing agent), a new product was produced. A reaction solution was cooled to room temperature. After filtration was conducted, a filter cake was rinsed with a small amount of ethanol. A solid obtained was stirred in dichloromethane (160 ml) for dissolved clarification. After filtration was conducted with silica gel, a filter cake was rinsed with a small amount of DCM. Deionized water was added into a filtrate obtained for washing for 3 times (80 ml/time). Liquid separation was conducted, and an organic phase was collected, and spin-dried. A crude product was recrystallized with tetrahydrofuran/methanol (1 g/8 v/15 v) for 4 times, and then dried to obtain 2.54 g of a red solid compound A7 with a yield of 48.3%. 2.54 g of the crude product A7 was sublimated and purified to obtain 1.49 g of a sublimated pure product A7 with a yield of 58.6%. Mass spectrometry was as follows: 1195.4 (M+H). .sup.1H NMR (400 MHz, CDCl.sub.3) δ 8.36 (d, 2H), 8.30 (d, J=0.6 Hz, 2H), 8.23 (s, 1H), 8.07 (d, 1H), 7.98 (dd, 1H), 7.84-7.67 (m, 4H), 7.56 (m, J=23.7 Hz, 2H), 7.46 (m, J=5.2 Hz, 3H), 7.39 (m, 2H), 7.35-7.23 (m, 4H), 7.01 (d, 1H), 6.92 (d, 1H), 2.87 (m, 1H), 2.34 (m, J=27.4, 17.4 Hz, 13H), 1.97 (m, J=6.9 Hz, 2H), 1.72 (m, J=28.4, 21.6 Hz, 6H), 1.20 (d, 3H).
Example 8 Synthesis of a compound A8
Synthesis of a Ligand La199
[0081] ##STR00381##
Synthesis of a Compound La199
[0082] With reference to the synthesis process and post-treatment and purification methods of the compound La385, only the corresponding raw materials were required to be changed. Mass spectrometry was as follows: 380.5 (M+H).
Synthesis of a Compound A8
[0083] ##STR00382## ##STR00383##
Synthesis of a Compound A8-1
[0084] With reference to the synthesis process and post-treatment and purification methods of the compound A1-1, only the corresponding raw materials were required to be changed. Mass spectrometry was as follows: 714.2 (M+H).
Synthesis of a compound A8-2
[0085] With reference to the synthesis process and post-treatment and purification methods of the compound A1-2, only the corresponding raw materials were required to be changed. The obtained compound was directly used in the next step without purification.
Synthesis of a compound A8
[0086] With reference to the synthesis process and post-treatment and purification methods of the compound A1, only the corresponding raw materials were required to be changed, and 3.77 g of a target compound A8 with a yield of 56.2% was obtained. 3.77 g of the crude product A8 was sublimated and purified to obtain 2.41 g of a sublimated pure product A8 with a yield of 63.9%. Mass spectrometry was as follows: 1195.5 (M+H). .sup.1H NMR (400 MHz, CDCl.sub.3) δ 8.37 (d, J=20.0 Hz, 2H), 7.95 (dd, 2H), 7.77 (m, J=5.0 Hz, 2H), 7.54 (d, J=15.0 Hz, 4H), 7.46 (m, 2H), 7.37 (m, 3H), 7.30 (m, 4H), 2.43 (d, 2H), 2.35 (d, J=10.0 Hz, 9H), 1.88 (m, 1H), 1.86-1.68 (m, 3H), 1.66 (m, 1H), 1.31 (m, 4H), 1.24 (m, 4H), 1.01 (m, J=5.7 Hz, 6H), 0.94 (m, 12H), 0.87 (d, 6H).
Example 9 Synthesis of a Compound A9
Synthesis of a Ligand La235
[0087] ##STR00384##
Synthesis of a Compound La235
[0088] With reference to the synthesis process and post-treatment and purification methods of the compound La385, only the corresponding raw materials were required to be changed. Mass spectrometry was as follows: 380.5 (M+H).
Synthesis of a compound A9
[0089] ##STR00385## ##STR00386##
Synthesis of a Compound A9-1
[0090] With reference to the synthesis process and post-treatment and purification methods of the compound A1-1, only the corresponding raw materials were required to be changed. Mass spectrometry was as follows: 714.2 (M+H).
Synthesis of a Compound A9-2
[0091] With reference to the synthesis process and post-treatment and purification methods of the compound A1-2, only the corresponding raw materials were required to be changed. The obtained compound was directly used in the next step without purification.
Synthesis of a Compound A9
[0092] With reference to the synthesis process and post-treatment and purification methods of the compound A1, only the corresponding raw materials were required to be changed, and 3.02 g of a target compound A9 with a yield of 49.7% was obtained. 3.02 g of the crude product A9 was sublimated and purified to obtain 2.15 g of a sublimated pure product A9 with a yield of 71.1%. Mass spectrometry was as follows: 1195.5 (M+H). .sup.1H NMR (400 MHz, CDCl.sub.3) δ 8.39 (d, J=20.0 Hz, 2H), 7.94 (dd, 2H), 7.75 (m, J=5.0 Hz, 2H), 7.53 (d, J=15.0 Hz, 4H), 7.45 (m, 2H), 7.36 (m, 4H), 7.32 (m, 3H), 2.69 (s, 3H), 2.43 (s, 2H), 2.34 (s, 6H), 1.88 (m, 1H), 1.86-1.68 (m, 3H), 1.66 (m, 1H), 1.31 (m, 4H), 1.24 (m, 4H), 1.01 (m, J=5.7 Hz, 6H), 0.94 (m, 12H), 0.87 (d, 6H).
Example 10 Synthesis of a Compound A10
Synthesis of a Ligand La457
[0093] ##STR00387##
[0094] With reference to the synthesis process and post-treatment and purification methods of the compound La385, only the corresponding raw materials were required to be changed. Mass spectrometry was as follows: 468.6 (M+H).
Synthesis of a compound A10
[0095] ##STR00388##
Synthesis of a compound A10-1
[0096] With reference to the synthesis process and post-treatment and purification methods of the compound A1-2, only the corresponding raw materials were required to be changed. The obtained compound was directly used in the next step without purification.
Synthesis of a Compound A10
[0097] With reference to the synthesis process and post-treatment and purification methods of the compound A1, only the corresponding raw materials were required to be changed, and 2.88 g of a target compound A10 with a yield of 42.1% was obtained. 2.88 g of the crude product A10 was sublimated and purified to obtain 1.77 g of a sublimated pure product A10 with a yield of 61.4%. Mass spectrometry was as follows: 1171.5 (M+H). .sup.1H NMR (400 MHz, CDCl.sub.3) δ 8.36 (d, 2H), 8.07 (d, 2H), 7.98 (dd, 3H), 7.83 (d, 1H), 7.77 (m, 1H), 7.54 (m, 2H), 7.47 (d, 2H), 7.39 (m, 2H), 7.31 (m, 2H), 7.15 (d, 2H), 6.92 (d, 2H), 2.32 (d, J=15.0 Hz, 12H), 1.88 (m, 4H), 1.76 (m, 4H), 1.66 (m, J=2.2 Hz, 7H), 1.31 (m, 4H), 1.24 (m, 4H), 1.01 (m, J=5.7 Hz, 5H), 0.94 (m, 12H).
Example 11 Synthesis of a Compound A11
Synthesis of a Ligand La397
[0098] ##STR00389##
[0099] With reference to the synthesis process and post-treatment and purification methods of the compound La385, only the corresponding raw materials were required to be changed. Mass spectrometry was as follows: 420.6 (M+H).
Synthesis of a Compound A11
[0100] ##STR00390##
Synthesis of a Compound A11-1
[0101] With reference to the synthesis process and post-treatment and purification methods of the compound A1-2, only the corresponding raw materials were required to be changed. The obtained compound was directly used in the next step without purification.
Synthesis of a Compound A11
[0102] With reference to the synthesis process and post-treatment and purification methods of the compound A1, only the corresponding raw materials were required to be changed, and 2.57 g of a target compound A11 with a yield of 40.6% was obtained. 2.57 g of the crude product A11 was sublimated and purified to obtain 1.65 g of a sublimated pure product A11 with a yield of 64.2%. Mass spectrometry was as follows: 1123.5 (M+H). .sup.1H NMR (400 MHz, CDCl.sub.3) δ 8.36 (d, 2H), 8.07 (d, 2H), 7.98 (dd, 2H), 7.77 (m, 2H), 7.50 (m, J=35.0 Hz, 2H), 7.35 (m, J=40.0 Hz, 4H), 6.92 (d, 2H), 2.87 (m, 1H), 2.32 (d, J=15.0 Hz, 9H), 1.88 (m, 4H), 1.82-1.55 (m, 12H), 1.27 (m, J=35.0 Hz, 7H), 1.17 (m, 6H), 1.08-1.02 (m, 2H), 1.01-0.89 (m, 16H).
Example 12 Synthesis of a Compound A12
Synthesis of a Ligand L144
[0103] ##STR00391##
[0104] With reference to the synthesis process and post-treatment and purification methods of the compound L50, only the corresponding raw materials were required to be changed. Mass spectrometry was as follows: 317.4 (M+H).
Synthesis of a Compound A12
[0105] ##STR00392##
Synthesis of a Compound A3-1
[0106] With reference to the synthesis process and post-treatment and purification methods of the compound A1-1, only the corresponding raw materials were required to be changed. Mass spectrometry was as follows: 714.2 (M+H).
Synthesis of a Compound A12-1
[0107] With reference to the synthesis process and post-treatment and purification methods of the compound A1-2, only the corresponding raw materials were required to be changed. The obtained compound was directly used in the next step without purification.
Synthesis of a Compound A12
[0108] With reference to the synthesis process and post-treatment and purification methods of the compound A1, only the corresponding raw materials were required to be changed, and 2.93 g of a target compound A12 with a yield of 51.3% was obtained. 2.93 g of the crude product A12 was sublimated and purified to obtain 1.86 g of a sublimated pure product A12 with a yield of 63.4%. Mass spectrometry was as follows: 1196.4 (M+H). .sup.1H NMR (400 MHz, CDCl.sub.3) δ 8.36 (d, 2H), 7.98 (d, 2H), 7.77 (d, 2H), 7.65 (m, J=25.0 Hz, 3H), 7.50 (m, J=35.0 Hz, 3H), 7.35 (m, J=40.0 Hz, 1H), 6.92 (s, 2H), 2.44 (s, 9H), 2.32 (d, J=15.0 Hz, 9H), 1.88 (m, 4H), 1.69 (t, J=26.1 Hz, 12H), 1.27 (m, J=35.0 Hz, 8H), 1.10-0.86 (m, 17H).
Example 13 Synthesis of a Compound A13
Synthesis of a Ligand L222
[0109] ##STR00393##
[0110] With reference to the synthesis process and post-treatment and purification methods of the compound L50, only the corresponding raw materials were required to be changed. Mass spectrometry was as follows: 224.3 (M+H).
Synthesis of a compound A13
[0111] ##STR00394##
Synthesis of a Compound A13-1
[0112] With reference to the synthesis process and post-treatment and purification methods of the compound A1-2, only the corresponding raw materials were required to be changed. The obtained compound was directly used in the next step without purification.
Synthesis of a Compound A13
[0113] With reference to the synthesis process and post-treatment and purification methods of the compound A1, only the corresponding raw materials were required to be changed, and 2.76 g of a target compound A13 with a yield of 41.2% was obtained. 2.76 g of the crude product A13 was sublimated and purified to obtain 1.79 g of a sublimated pure product A13 with a yield of 64.8%. Mass spectrometry was as follows: 1003.3 (M+H). .sup.1H NMR (400 MHz, CDCl.sub.3) δ 8.13 (d, 2H), 8.07 (d, 2H), 7.98 (dd, 1H), 7.77 (d, 1H), 7.66 (m, 1H), 7.50 (m, J=35.0 Hz, 2H), 7.40 (m, J=15.0 Hz, 4H), 7.31 (m, 1H), 6.92 (d, 2H), 2.32 (d, J=15.0 Hz, 9H), 1.88 (m, 2H), 1.76 (m, 2H), 1.66 (m, J=2.2 Hz, 4H), 1.31 (m, 4H), 1.24 (m, 4H), 1.01 (m, J=5.7 Hz, 4H), 0.94 (m, 12H).
Example 14 Synthesis of a Compound A14
Synthesis of a Ligand L174
[0114] ##STR00395##
[0115] With reference to the synthesis process and post-treatment and purification methods of the compound L50, only the corresponding raw materials were required to be changed. Mass spectrometry was as follows: 392.5 (M+H).
Synthesis of a compound A14
[0116] ##STR00396##
Synthesis of a Compound A14-1
[0117] With reference to the synthesis process and post-treatment and purification methods of the compound A1-1, only the corresponding raw materials were required to be changed. Mass spectrometry was as follows: 741.4 (M+H).
Synthesis of a compound A14-2
[0118] With reference to the synthesis process and post-treatment and purification methods of the compound A1-2, only the corresponding raw materials were required to be changed. The obtained compound was directly used in the next step without purification.
Synthesis of a compound A14
[0119] With reference to the synthesis process and post-treatment and purification methods of the compound A1, only the corresponding raw materials were required to be changed, and 2.67 g of a target compound A14 with a yield of 43.1% was obtained. 2.67 g of the crude product A14 was sublimated and purified to obtain 1.68 g of a sublimated pure product A14 with a yield of 62.9%. Mass spectrometry was as follows: 1213.6 (M+H). .sup.1H NMR (400 MHz, CDCl.sub.3) δ 8.32 (d, 2H), 8.07 (d, 2H), 7.98 (dd, 2H), 7.80 (dd, J=25.0 Hz, 2H), 7.51 (m, J=25.0 Hz, 4H), 7.35 (m, J=40.0 Hz, 3H), 7.16 (d, 2H), 6.92 (d, 2H), 2.87 (m, 1H), 2.32 (d, J=15.0 Hz, 12H), 1.88 (m, 4H), 1.76 (m, 4H), 1.66 (m, J=2.2 Hz, 8H), 1.27 (m, J=35.0 Hz, 8H), 1.17 (d, 6H), 1.01 (m, J=5.7 Hz, 5H), 0.94 (m, 12H).
Example 15 Synthesis of a Compound A15
Synthesis of a Compound A15
[0120] ##STR00397##
Synthesis of a Compound A15
[0121] With reference to the synthesis process and post-treatment and purification methods of the compound A1, only the corresponding raw materials were required to be changed, and 2.71 g of a target compound A15 with a yield of 44.2% was obtained. 2.71 g of the crude product A15 was sublimated and purified to obtain 1.62 g of a sublimated pure product A15 with a yield of 59.7%. Mass spectrometry was as follows: 1109.5 (M+H). .sup.1H NMR (400 MHz, CDCl.sub.3) δ 8.36 (d, J=15.0 Hz, 2H), 8.07 (d, J=2.9 Hz, 2H), 7.98 (dd, J=14.6, 3.4 Hz, 1H), 7.77 (d, J=15.0 Hz, 2H), 7.54 (dd, J=14.7, 3.4 Hz, 1H), 7.47 (dd, J=14.9, 3.0 Hz, 2H), 7.38 (tt, J=9.2, 4.5 Hz, 3H), 7.31 (td, J=14.8, 3.4 Hz, 2H), 6.92 (d, J=3.1 Hz, 2H), 2.32 (d, J=15.0 Hz, 9H), 1.88 (m, 4H), 1.81-1.59 (m, 12H), 1.00 (m, J=5.0 Hz, 18H), 0.89 (m, 9H), 0.86 (t, J=3.5 Hz, 2H).
Example 16 Synthesis of a Compound A16
Synthesis of a Compound A16
[0122] ##STR00398##
Synthesis of a Compound A16
[0123] With reference to the synthesis process and post-treatment and purification methods of the compound A1, only the corresponding raw materials were required to be changed, and 2.83 g of a target compound A16 with a yield of 43.9% was obtained. 2.83 g of the crude product A16 was sublimated and purified to obtain 1.82 g of a sublimated pure product A16 with a yield of 64.3%. Mass spectrometry was as follows: 1137.5 (M+H). .sup.1H NMR (400 MHz, CDCl.sub.3) δ 8.36 (d, J=15.0 Hz, 2H), 8.07 (d, J=2.9 Hz, 2H), 7.98 (dd, J=14.6, 3.4 Hz, 1H), 7.77 (d, J=15.0 Hz, 2H), 7.54 (dd, J=14.7, 3.4 Hz, 1H), 7.47 (dd, J=14.9, 3.0 Hz, 2H), 7.38 (tt, J=9.2, 4.5 Hz, 3H), 7.31 (td, J=14.8, 3.4 Hz, 2H), 6.92 (d, J=3.1 Hz, 2H), 2.32 (d, J=15.0 Hz, 9H), 1.88 (m, 4H), 1.76 (m, 4H), 1.66 (m, J=2.2 Hz, 8H), 1.00 (m, 15H), 0.89 (m, 18H).
Example 17 Synthesis of a Compound A17
Synthesis of a Ligand L65
[0124] ##STR00399##
[0125] With reference to the synthesis process and post-treatment and purification methods of the compound L50, only the corresponding raw materials were required to be changed. Mass spectrometry was as follows: 290.4 (M+H).
Synthesis of a compound A17
[0126] ##STR00400##
Synthesis of a Compound A17-1
[0127] With reference to the synthesis process and post-treatment and purification methods of the compound A1-2, only the corresponding raw materials were required to be changed. The obtained compound was directly used in the next step without purification.
Synthesis of a compound A17
[0128] With reference to the synthesis process and post-treatment and purification methods of the compound A1, only the corresponding raw materials were required to be changed, and 3.16 g of a target compound A17 with a yield of 46.1% was obtained. 3.16 g of the crude product A17 was sublimated and purified to obtain 2.23 g of a sublimated pure product A17 with a yield of 70.5%. Mass spectrometry was as follows: 1097.5 (M+H). .sup.1H NMR (400 MHz, CDCl.sub.3) δ 8.60 (d, 1H), 8.36 (d, 1H), 8.07 (d, 1H), 7.96 (m, J=15.0 Hz, 2H), 7.77 (dd, 2H), 7.66 (m, 2H), 7.50 (dd, J=35.0 Hz, 2H), 7.44-7.26 (m, 3H), 7.19 (dd, 2H), 6.92 (s, 1H), 2.47 (d, 2H), 2.32 (d, J=15.0 Hz, 9H), 1.88 (m, 2H), 1.78 (m, J=20.0 Hz, 3H), 1.66 (m, J=2.2 Hz, 4H), 1.00 (m, J=5.0 Hz, 16H), 0.88 (m, J=15.0 Hz, 18H).
Example 18 Synthesis of a Compound A18
Synthesis of a Ligand La493
[0129] ##STR00401##
[0130] With reference to the synthesis process and post-treatment and purification methods of the compound La385, only the corresponding raw materials were required to be changed. Mass spectrometry was as follows: 434.6 (M+H).
Synthesis of a compound A18
[0131] ##STR00402## ##STR00403##
Synthesis of a compound A18-1
[0132] With reference to the synthesis process and post-treatment and purification methods of the compound A1-1, only the corresponding raw materials were required to be changed. Mass spectrometry was as follows: 768.4 (M+H).
Synthesis of a compound A18-2
[0133] With reference to the synthesis process and post-treatment and purification methods of the compound A1-2, only the corresponding raw materials were required to be changed. The obtained compound was directly used in the next step without purification.
Synthesis of a compound A18
[0134] With reference to the synthesis process and post-treatment and purification methods of the compound A1, only the corresponding raw materials were required to be changed, and 3.41 g of a target compound A18 with a yield of 43.8% was obtained. 3.41 g of the crude product A18 was sublimated and purified to obtain 2.33 g of a sublimated pure product A18 with a yield of 68.3%. Mass spectrometry was as follows: 1153.6 (M+H). .sup.1H NMR (400 MHz, CDCl.sub.3) δ 8.60 (d, 1H), 8.07 (d, 1H), 7.96 (m, J=15.0 Hz, 2H), 7.89 (dd, 2H), 7.66 (t, 1H), 7.54 (dd, 2H), 7.42-7.27 (m, 4H), 7.19 (dd, 2H), 6.92 (d, 1H), 2.47 (d, 4H), 2.32 (d, J=15.0 Hz, 9H), 1.88 (m, 2H), 1.78 (m, J=20.0 Hz, 4H), 1.66 (m, J=2.2 Hz, 4H), 1.00 (m, J=5.0 Hz, 16H), 0.88 (m, J=15.0 Hz, 24H).
Example 19 Synthesis of a Compound A19
Synthesis of a Ligand La529
[0135] ##STR00404##
[0136] With reference to the synthesis process and post-treatment and purification methods of the compound La385, only the corresponding raw materials were required to be changed. Mass spectrometry was as follows: 434.6 (M+H).
Synthesis of a compound A19
[0137] ##STR00405##
Synthesis of a compound A19
[0138] With reference to the synthesis process and post-treatment and purification methods of the compound A1, only the corresponding raw materials were required to be changed, and 3.03 g of a target compound A19 with a yield of 41.4% was obtained. 3.03 g of the crude product A19 was sublimated and purified to obtain 1.83 g of a sublimated pure product A19 with a yield of 60.3%. Mass spectrometry was as follows: 1153.6 (M+H). .sup.1H NMR (400 MHz, CDCl.sub.3) δ 8.60 (d, 1H), 8.39 (d, 1H), 8.07 (d, 1H), 7.96 (m, J=15.0 Hz, 2H), 7.66 (m, 4H), 7.54 (dd, 2H), 7.44-7.24 (m, 3H), 7.21 (dd, 1H), 6.91 (d, 1H), 2.43 (d, 4H), 2.35 (d, J=15.0 Hz, 9H), 2.06-1.55 (m, 10H), 1.03 (m, J=5.0 Hz, 16H), 0.86 (m, J=15.0 Hz, 24H).
Example 20 Synthesis of a Compound A20
Synthesis of a Ligand La1267
[0139] ##STR00406##
[0140] With reference to the synthesis process and post-treatment and purification methods of the compound L112, only the corresponding raw materials were required to be changed. Mass spectrometry was as follows: 393.5 (M+H).
Synthesis of a compound A20
[0141] ##STR00407##
Synthesis of a Compound A20-1
[0142] With reference to the synthesis process and post-treatment and purification methods of the compound A1-1, only the corresponding raw materials were required to be changed. Mass spectrometry was as follows: 727.3 (M+H).
Synthesis of a Compound A20-2
[0143] With reference to the synthesis process and post-treatment and purification methods of the compound A1-2, only the corresponding raw materials were required to be changed. The obtained compound was directly used in the next step without purification.
Synthesis of a compound A20
[0144] With reference to the synthesis process and post-treatment and purification methods of the compound A1, only the corresponding raw materials were required to be changed, and 2.96 g of a target compound A20 with a yield of 39.8% was obtained. 2.96 g of the crude product A20 was sublimated and purified to obtain 1.84 g of a sublimated pure product A20 with a yield of 62.1%. Mass spectrometry was as follows: 1112.5 (M+H). .sup.1H NMR (400 MHz, CDCl.sub.3) δ 8.60 (d, 2H), 8.36 (d, 2H), 8.07 (d, 2H), 7.95 (dd, 1H), 7.71 (m, J=55.0 Hz, 2H), 7.41 (m, J=60.0 Hz, 2H), 7.19 (dd, 2H), 7.01 (d, 1H), 6.92 (d, 1H), 2.68 (s, 3H), 2.47 (d, 2H), 2.32 (d, J=15.0 Hz, 9H), 1.99-1.56 (m, 9H), 1.00 (m, J=5.0 Hz, 16H), 0.94-0.80 (m, 18H).
Example 21 Synthesis of a Compound A21
Synthesis of a Ligand La1307
[0145] ##STR00408##
[0146] With reference to the synthesis process and post-treatment and purification methods of the compound L221, only the corresponding raw materials were required to be changed. Mass spectrometry was as follows: 396.5 (M+H).
Synthesis of a compound A21
[0147] ##STR00409##
Synthesis of a Compound A21-1
[0148] With reference to the synthesis process and post-treatment and purification methods of the compound A1-1, only the corresponding raw materials were required to be changed. Mass spectrometry was as follows: 730.3 (M+H).
Synthesis of a compound A21-2
[0149] With reference to the synthesis process and post-treatment and purification methods of the compound A1-2, only the corresponding raw materials were required to be changed. The obtained compound was directly used in the next step without purification.
Synthesis of a compound A21
[0150] With reference to the synthesis process and post-treatment and purification methods of the compound A1, only the corresponding raw materials were required to be changed, and 2.53 g of a target compound A21 with a yield of 38.1% was obtained. 2.53 g of the crude product A21 was sublimated and purified to obtain 1.62 g of a sublimated pure product A21 with a yield of 64.0%. Mass spectrometry was as follows: 1115.5 (M+H). .sup.1H NMR (400 MHz, CDCl.sub.3) δ 8.62 (d, 2H), 8.35 (d, 2H), 8.10 (d, 2H), 7.94 (dd, 1H), 7.72 (m, J=55.0 Hz, 2H), 7.41 (m, J=60.0 Hz, 2H), 7.19 (dd, 2H), 7.01 (d, 1H), 6.92 (d, 1H), 2.47 (d, 2H), 2.32 (d, J=15.0 Hz, 9H), 1.99-1.56 (m, 9H), 1.00 (m, J=5.0 Hz, 16H), 0.94-0.80 (m, 18H).
Example 22 Synthesis of a Compound A22
Synthesis of a Ligand La386
[0151] ##STR00410##
[0152] With reference to the synthesis process and post-treatment and purification methods of the compound La385, only the corresponding raw materials were required to be changed. Mass spectrometry was as follows: 394.5 (M+H).
Synthesis of a compound A22
[0153] ##STR00411##
Synthesis of a Compound A22-1
[0154] With reference to the synthesis process and post-treatment and purification methods of the compound A1-1, only the corresponding raw materials were required to be changed. Mass spectrometry was as follows: 728.4 (M+H).
Synthesis of a compound A22-2
[0155] With reference to the synthesis process and post-treatment and purification methods of the compound A1-2, only the corresponding raw materials were required to be changed. The obtained compound was directly used in the next step without purification.
Synthesis of a Compound A22
[0156] With reference to the synthesis process and post-treatment and purification methods of the compound A1, only the corresponding raw materials were required to be changed, and 2.66 g of a target compound A22 with a yield of 40.1% was obtained. 2.66 g of the crude product A22 was sublimated and purified to obtain 1.84 g of a sublimated pure product A22 with a yield of 69.1%. Mass spectrometry was as follows: 1113.5 (M+H). .sup.1H NMR (400 MHz, CDCl.sub.3) δ 8.60 (d, 1H), 8.45 (dd, 1H), 8.36 (dd, 1H), 8.07 (d, 1H), 7.95 (dd, 1H), 7.86 (dd, 1H), 7.77 (dd, 1H), 7.66 (m, 2H), 7.56 (m, 2H), 7.47 (m, 2H), 7.33 (m, J=20.0 Hz, 2H), 7.19 (dd, 1H), 6.92 (d, 1H), 2.47 (d, 2H), 2.32 (d, J=15.0 Hz, 9H), 1.88 (m, 2H), 1.78 (m, J=20.0 Hz, 3H), 1.66 (m, J=2.2 Hz, 4H), 1.00 (m, J=5.0 Hz, 16H), 0.88 (m, J=15.0 Hz, 18H).
Example 23 Synthesis of a Compound A23
Synthesis of a Ligand La387
[0157] ##STR00412##
[0158] With reference to the synthesis process and post-treatment and purification methods of the compound La385, only the corresponding raw materials were required to be changed. Mass spectrometry was as follows: 441.4 (M+H).
Synthesis of a compound A23
[0159] ##STR00413##
Synthesis of a Compound A23-1
[0160] With reference to the synthesis process and post-treatment and purification methods of the compound A1-1, only the corresponding raw materials were required to be changed. Mass spectrometry was as follows: 775.3 (M+H).
Synthesis of a compound A23-2
[0161] With reference to the synthesis process and post-treatment and purification methods of the compound A1-2, only the corresponding raw materials were required to be changed. The obtained compound was directly used in the next step without purification.
Synthesis of a compound A23
[0162] With reference to the synthesis process and post-treatment and purification methods of the compound A1, only the corresponding raw materials were required to be changed, and 2.31 g of a target compound A23 with a yield of 36.1% was obtained. 2.31 g of the crude product A23 was sublimated and purified to obtain 1.38 g of a sublimated pure product A23 with a yield of 59.7%. Mass spectrometry was as follows: 1160.4 (M+H). .sup.1H NMR (400 MHz, CDCl.sub.3) δ 8.60 (d, 1H), 8.45 (dd, 1H), 8.36 (dd, 1H), 8.07 (d, 1H), 7.95 (dd, 1H), 7.86 (dd, 1H), 7.77 (dd, 2H), 7.66 (m, 2H), 7.58-7.38 (m, 3H), 7.35 (d, 2H), 7.19 (d, 1H), 6.92 (d, 1H), 2.47 (d, 2H), 2.32 (d, J=15.0 Hz, 9H), 1.88 (m, 2H), 1.78 (m, J=20.0 Hz, 3H), 1.66 (m, J=2.2 Hz, 4H), 1.00 (m, J=5.0 Hz, 16H), 0.88 (m, J=15.0 Hz, 18H).
Example 24 Synthesis of a Compound A24
Synthesis of a Ligand La388
[0163] ##STR00414##
[0164] With reference to the synthesis process and post-treatment and purification methods of the compound La385, only the corresponding raw materials were required to be changed. Mass spectrometry was as follows: 441.4 (M+H).
Synthesis of a compound A24
[0165] ##STR00415##
Synthesis of a compound A24-1
[0166] With reference to the synthesis process and post-treatment and purification methods of the compound A1-1, only the corresponding raw materials were required to be changed. Mass spectrometry was as follows: 738.4 (M+H).
Synthesis of a compound A24-2
[0167] With reference to the synthesis process and post-treatment and purification methods of the compound A1-2, only the corresponding raw materials were required to be changed. The obtained compound was directly used in the next step without purification.
Synthesis of a compound A24
[0168] With reference to the synthesis process and post-treatment and purification methods of the compound A1, only the corresponding raw materials were required to be changed, and 2.41 g of a target compound A24 with a yield of 40.3% was obtained. 2.41 g of the crude product A24 was sublimated and purified to obtain 1.55 g of a sublimated pure product A24 with a yield of 64.3%. Mass spectrometry was as follows: 1123.5 (M+H). .sup.1H NMR (400 MHz, CDCl.sub.3) δ 8.60 (d, 1H), 8.36 (d, 1H), 8.07 (d, 1H), 7.92 (m, J=25.0 Hz, 3H), 7.77 (d, 2H), 7.66 (m, 3H), 7.47 (d, 2H), 7.35 (d, 2H), 7.19 (dd, 1H), 6.92 (d, 1H), 2.47 (d, 2H), 2.32 (d, J=15.0 Hz, 9H), 1.88 (m, 2H), 1.78 (m, J=20.0 Hz, 3H), 1.72-1.57 (m, 10H), 1.00 (m, J=5.0 Hz, 16H), 0.88 (m, J=15.0 Hz, 18H).
Example 25 Synthesis of a compound A25
Synthesis of a Ligand La389
[0169] ##STR00416##
[0170] With reference to the synthesis process and post-treatment and purification methods of the compound La385, only the corresponding raw materials were required to be changed. Mass spectrometry was as follows: 391.5 (M+H).
Synthesis of a compound A25
[0171] ##STR00417##
Synthesis of a Compound A25-1
[0172] With reference to the synthesis process and post-treatment and purification methods of the compound A1-1, only the corresponding raw materials were required to be changed. Mass spectrometry was as follows: 725.5 (M+H).
Synthesis of a compound A25-2
[0173] With reference to the synthesis process and post-treatment and purification methods of the compound A1-2, only the corresponding raw materials were required to be changed. The obtained compound was directly used in the next step without purification.
Synthesis of a compound A25
[0174] With reference to the synthesis process and post-treatment and purification methods of the compound A1, only the corresponding raw materials were required to be changed, and 2.53 g of a target compound A25 with a yield of 38.1% was obtained. 2.53 g of the crude product A25 was sublimated and purified to obtain 1.72 g of a sublimated pure product A25 with a yield of 65.9%. Mass spectrometry was as follows: 1110.5 (M+H). .sup.1H NMR (400 MHz, CDCl.sub.3) δ 8.60 (d, 1H), 8.52 (d, 1H), 8.35 (m, J=10.0 Hz, 2H), 8.07 (d, 1H), 7.95 (dd, 2H), 7.77 (d, 2H), 7.66 (m, 2H), 7.52-7.31 (m, 3H), 7.16 (m, J=25.0 Hz, 2H), 6.92 (d, 1H), 3.82 (s, 3H), 2.47 (d, 2H), 2.32 (d, J=15.0 Hz, 9H), 1.88 (m, 2H), 1.78 (m, J=20.0 Hz, 3H), 1.66 (m, J=2.2 Hz, 4H), 1.00 (m, J=5.0 Hz, 15H), 0.88 (m, J=15.0 Hz, 18H).
[0175] Other compounds can be synthesized and sublimated by using corresponding materials according to same or similar methods.
[0176] Application Example: Manufacture of an organic electroluminescent device
[0177] A glass substrate with a size of 50 mm*50 mm*1.0 mm including an ITO (100 nm) transparent electrode was ultrasonically cleaned in ethanol for 10 minutes, dried at 150° C., and then treated with N.sub.2 plasma for 30 minutes. The washed glass substrate was installed on a substrate support of a vacuum evaporation device. At first, a compound HATCN for covering the transparent electrode was evaporated on the surface of the side having a transparent electrode line to form a thin film with a thickness of 5 nm. Next, a layer of HTM1 was evaporated to form a thin film with a thickness of 60 nm. Then, a layer of HTM2 was evaporated on the HTM1 thin film to form a thin film with a thickness of 10 nm. After that, a main material CBP and a doping compound (including a reference compound X and a compound AX of the present invention) were co-evaporated on the HTM2 film layer to obtain a film with a thickness of 30 nm, where a ratio of the main material to the doping material was 90%:10%. An electron transport layer (ETL) film layer (25 nm) and a LiQ film layer (1 nm) was evaporated on a light-emitting layer in sequence. At last, a layer of A1 (100 nm) was evaporated to serve as an electrode.
##STR00418##
Evaluation
[0178] Properties of a device obtained above were tested. In various examples and comparative examples, a constant-current power supply (Keithley 2400) was used, a current at a fixed density was used for flowing through light-emitting elements, and a spectroradiometer (CS 2000) was used for testing the light-emitting spectrum. Meanwhile, the voltage value was measured, and the time (LT90) when the brightness was reduced to 90% of an initial brightness was tested. Results are shown as follows.
TABLE-US-00002 Starting Current Peak LT90@ Doping voltage efficiency wavelength 3000 material V Cd/A nm nits Example 1 A1 4.11 28 614 221 Example 2 A2 4.13 30 615 244 Example 3 A3 4.09 35 615 246 Example 4 A4 4.08 32 616 228 Example 5 A5 4.10 31 615 249 Example 6 A6 4.11 29 614 238 Example 7 A7 4.13 28 615 332 Example 8 A8 4.10 34 616 301 Example 9 A9 4.09 35 616 355 Example 10 A10 4.12 31 615 281 Example 11 A11 4.10 29 615 279 Example 12 A12 4.08 31 615 211 Example 13 A13 4.08 27 614 184 Example 14 A14 4.07 29 615 209 Example 15 A15 4.09 29 615 239 Example 16 A16 4.10 29 615 268 Example 17 A17 4.11 30 615 298 Example 18 A18 4.12 31 615 288 Example 19 A19 4.13 30 615 264 Example 20 A20 4.10 31 615 269 Example 21 A21 4.09 31 615 333 Example 22 A22 4.10 31 615 268 Example 23 A23 4.12 30 616 256 Example 24 A24 4.10 30 615 262 Example 25 A25 4.09 31 615 228 Comparative Reference 4.21 21 610 108 Example 1 compound 1 Comparative Reference 4.18 20 612 120 Example 2 compound 2 Comparative Reference 4.25 21 611 98 Example 3 compound 3 Comparative Reference 4.28 19 608 86 Example 4 compound 4
[0179] Through comparison of the data in the above table, it can be seen that compared with reference compounds, the compound of the present invention used as a dopant in an organic electroluminescent device has the advantages that more excellent properties, such as driving voltage, luminescence efficiency, and device service life, are achieved.
[0180] According to the above results, it is indicated that the compound of the present invention has the advantages of high optical and electrochemical stability, high color saturation, high luminescence efficiency, and long service life, and can be used in organic electroluminescent devices. In particular, the metal complex has the potential for application in the OLED industry as a red light-emitting dopant.